One study showed a response rate of 40%.
"Response" in this context, means the tumor shrunk. It is rare for tumors to disappear on regorafenib. Clinical benefit depends to a great extent on the overall fitness of the patient (performance status), extent of disease, and number of prior therapies.
Courage and faith, Marilyn994, and my best wishes for you.